Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours ยท Estimated delivery Oct 28 - Nov 2
Usami and K
Engelstoft, MS, Egerod, KL, Holst, B, Schwartz, TW
Claims for GLP-1s Increased Four-Fold Between 2019 and 2024 In accordance with an increase in both the number of Medicare Part D enrollees using GLP-1s and spending on these products, the number of claims for GLP-1s increased four-fold between 2019 and 2024, from 4.8 million to 21.8 million, with claims doubling between 2022 and 2024 alone
The company increasingly relies on GLP-1 based weight loss treatments, including compounded semaglutide and planned microdosing regimens, as major growth drivers
US$ 29.13
US$ 20.42
US$ 22.91
US$ 20.97
US$ 26.63
US$ 21.62
US$ 21.19
